» Articles » PMID: 34733891

Predicting All-Cause Mortality Risk in Atrial Fibrillation Patients: A Novel LASSO-Cox Model Generated From a Prospective Dataset

Overview
Date 2021 Nov 4
PMID 34733891
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Although mortality remains high in patients with atrial fibrillation (AF), there have been limited studies exploring machine learning (ML) models on mortality risk prediction in patients with AF. This study sought to develop an ML model that captures important variables in order to predict all-cause mortality in AF patients. In this single center prospective study, an ML-based mortality prediction model was developed and validated using a dataset of 2,012 patients who experienced AF from November 2018 to February 2020 at the First Affiliated Hospital of Shantou University Medical College. The dataset was randomly divided into a training set (70%, = 1,223) and a validation set (30%, = 552). A total of 122 features were collected for variable selection. Least absolute shrinkage and selection operator (LASSO) and random forest (RF) algorithms were used for variable selection. Ten ML models were developed using variables selected by LASSO or RF. The best model was selected and compared with conventional risk scores. A nomogram and user-friendly online tool were developed to facilitate the mortality predictions and management recommendations. Thirteen features were selected by the LASSO regression algorithm. The LASSO-Cox model achieved an area under the curve (AUC) of 0.842 in the training dataset, and 0.854 in the validation dataset. A nomogram based on eight independent features was developed for the prediction of survival at 30, 180, and 365 days following discharge. Both the time dependent receiver operating characteristic (ROC) and decision curve analysis (DCA) showed better performances of the nomogram compared to the CHADS-VASc and HAS-BLED models. The LASSO-Cox mortality predictive model shows potential benefits in death risk evaluation for AF patients over the 365-day period following discharge. This novel ML approach may also provide physicians with personalized management recommendations.

Citing Articles

Prognostic value of glycaemic variability for mortality in critically ill atrial fibrillation patients and mortality prediction model using machine learning.

Chen Y, Yang Z, Liu Y, Gue Y, Zhong Z, Chen T Cardiovasc Diabetol. 2024; 23(1):426.

PMID: 39593120 PMC: 11590403. DOI: 10.1186/s12933-024-02521-7.


A Predictive Nomogram of In-Hospital Mortality After 48 h for Atrial Fibrillation Patients in the Coronary Care Unit.

Wang W, Liu L, Jin L, Hu B Clin Cardiol. 2024; 47(9):e70017.

PMID: 39289906 PMC: 11408711. DOI: 10.1002/clc.70017.


An Online Pre-procedural Nomogram for the Prediction of Contrast-Associated Acute Kidney Injury in Patients Undergoing Coronary Angiography.

Li D, Jiang H, Yang X, Lin M, Gao M, Chen Z Front Med (Lausanne). 2022; 9:839856.

PMID: 35360720 PMC: 8961873. DOI: 10.3389/fmed.2022.839856.


Machine learning in the detection and management of atrial fibrillation.

Wegner F, Plagwitz L, Doldi F, Ellermann C, Willy K, Wolfes J Clin Res Cardiol. 2022; 111(9):1010-1017.

PMID: 35353207 PMC: 9424134. DOI: 10.1007/s00392-022-02012-3.

References
1.
Park S, Freedman N, Haiman C, Le Marchand L, Wilkens L, Setiawan V . Association of Coffee Consumption With Total and Cause-Specific Mortality Among Nonwhite Populations. Ann Intern Med. 2017; 167(4):228-235. PMC: 7494322. DOI: 10.7326/M16-2472. View

2.
Andersson T, Magnuson A, Bryngelsson I, Frobert O, Henriksson K, Edvardsson N . All-cause mortality in 272,186 patients hospitalized with incident atrial fibrillation 1995-2008: a Swedish nationwide long-term case-control study. Eur Heart J. 2013; 34(14):1061-7. PMC: 3618889. DOI: 10.1093/eurheartj/ehs469. View

3.
Ambale-Venkatesh B, Yang X, Wu C, Liu K, Hundley W, McClelland R . Cardiovascular Event Prediction by Machine Learning: The Multi-Ethnic Study of Atherosclerosis. Circ Res. 2017; 121(9):1092-1101. PMC: 5640485. DOI: 10.1161/CIRCRESAHA.117.311312. View

4.
Darvesh S, Arora R, Martin E, Magee D, Hopkins D, Armour J . Cholinesterase inhibitors modify the activity of intrinsic cardiac neurons. Exp Neurol. 2004; 188(2):461-70. DOI: 10.1016/j.expneurol.2004.05.002. View

5.
Patel N, Deshmukh A, Pant S, Singh V, Patel N, Arora S . Contemporary trends of hospitalization for atrial fibrillation in the United States, 2000 through 2010: implications for healthcare planning. Circulation. 2014; 129(23):2371-9. DOI: 10.1161/CIRCULATIONAHA.114.008201. View